|
|
||||||||
1 University of Wisconsin-Madison, Department of Dairy Science, Madison, 53706
2 Alta Genetics, Inc., Watertown, WI 53094
3 Dairy Records Management Systems, Raleigh, NC 27695
Corresponding author: Kent Weigel; e-mail: kweigel{at}wisc.edu.
| ABSTRACT |
|---|
|
|
|---|
Key Words: health traits metabolic disorders genetic correlations disease incidence
Abbreviation key: CYST = cystic ovaries, DA = displaced abomasum, DPR = daughter pregnancy rate, DRMS = Dairy Records Management Systems, KET = ketosis, LAME = lameness, LIR = lactation incidence rate, MAST = mastitis, MET = metritis, PL = length of productive life
| INTRODUCTION |
|---|
|
|
|---|
Beaudeau et al. (1999) reported that metabolic disorders seem to have a smaller impact on the likelihood of culling than poor milk production or poor reproductive performance. They note, however, that a metabolic disorder may not cause culling immediately; it may decrease the animals milk production or impair its reproductive performance, such that the animal is culled at a later date. Pryce and Brotherstone (1999) reported a significant relationship between likelihood of culling and calving interval and clinical mastitis (MAST); estimated genetic correlations were 0.44 and 0.22 respectively.
In Danish Holsteins, Sander-Nielsen et al. (1999) reported low heritability estimates for clinical MAST (0.05), metabolic disorders (0.01), and feet and leg disorders (0.01). However, they estimated relatively high genetic correlations between longevity and both MAST (0.52) and metabolic disorders (0.43). Sander-Nielsen et al. (1999) also noted modest genetic correlations between longevity and both feet and leg diseases (0.18) and reproductive disorders (0.17). Other studies have shown that genetic and phenotypic correlations between various metabolic diseases, such as displaced abomasum (DA) and ketosis (KET) are large and positive (Uribe et al., 1995; Shaver, 1997).
The present study focuses on data regarding the incidence of health disorders on commercial farms, as collected electronically from on-farm herd management software programs. On-farm records provide the only opportunity for direct selection for disease resistance in US dairy cattle, because recording of health disorders is not mandatory, and many farm employees routinely diagnose and treat diseases without the involvement of a veterinarian. Despite the promise of on-farm health data, research regarding the usefulness of such data for genetic evaluation purposes is lacking, most likely because recording practices are not standardized across farms, and mechanisms for routine retrieval of such data do not exist.
The objectives of this study were: 1) to compute genetic correlations between health traits commonly recorded in on-farm herd management software programs; 2) to assess relationships between these traits and other traits that are routinely evaluated in US dairy sires, and 3) to examine alternatives for including these traits in a genetic selection program.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Two separate analyses were carried out, one that used all available lactation records, and one that consisted of first parity records only. Although the former included much more data, it was susceptible to selection bias (because some animals lacked first parity records) and improper modeling of the covariance structure (because repeated records on the same animal were not independent). Therefore, only results of the first parity analysis are reported. Additional details regarding data collection and editing, as well as a summary of the number of usable herds, lactation records, cows, and sires is provided in Zwald et al. (2004). Likewise, details regarding single-trait analyses of these disease incidence data are provided by Zwald et al. (2004).
In the present study, incidence data (presence or absence during the first lactation) for the 6 aforementioned health disorders were analyzed simultaneously using a multiple-trait threshold sire model that accounted for the binary (0, 1) nature of the data. Similar methodology has been used for analyzing clinical MAST data from various periods of the lactation (e.g., Heringstad et al., 2003; Chang et al., accepted). In matrix notation, the model for liability to disease in first lactation was as follows:
![]() |
where
= a vector of unobserved liabilities to a particular disease, h = vector of random herd-year-season effects (JanJune, JulyDec), s = vector of random sire effects, distributed as N(0, A
Vs), where A is the relationship matrix between sires, and Vs is the genetic covariance matrix between the 6 health disorders considered in this study, e = vector of random residual effects, distributed as N(0, I
Ve), where I is an identity matrix and Ve is the residual correlation matrix between the 6 health disorders considered in this study (i.e., residual variances were constrained to unity for computational reasons), and Zh, and Zs = corresponding incidence matrices.
Posterior means of sire transmitting abilities were transformed from the underlying liability scale to probability of disease using the following function:
![]() |
where Pij = probability of disease i for daughters of sire j,
= standard normal cumulative density function, µ= probit function corresponding to the mean liability of disease i, and
ij = posterior mean of liability to disease i for daughters of sire j.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
Although it would have been ideal to include those herds that recorded all 6 health disorders consistently, this was not possible. Many herds provided useful data for only 1 or 2 diseases, as noted in Table 1
, and all other traits (diseases) were considered missing for these herds. This reduced the number of links or connections between herds for certain pairs of disorders. Overall, only 43 herds reported useful data for all 6 disorders examined in this study, so the majority of animals had missing records for one or more individual diseases. In some herds, recording practices were somewhat ambiguous, and specific diseases could not be distinguished. For example, an abbreviation such as "PEN" could mean that the cow received penicillin, or it could mean that the cow was moved to a different pen. The challenges regarding data recording and standardization are further discussed by Zwald et al. (2004).
|
|
Table 3
shows product-moment correlations between PTA for disease incidence traits from the present study and PTA for production, type, and fitness traits from the February, 2004 USDA Animal Improvement Programs Laboratory (Beltsville, MD) and the Holstein Association USA (Brattleboro, VT) sire summaries. Because of the low reliability of sire PTA for the 6 disease traits considered herein, correlations shown in Table 3
tend to underestimate the true genetic correlations between these traits, and attention should focus on the direction of these relationships, rather than the magnitude.
|
A negative association was found between all 6 disease traits and both PL and DPR, indicating that the incidence of disease seems to hamper reproductive performance and impair cow survival, as suggested by previous researchers (Guard, 1998; Rauw et al., 1998; Sander-Nielsen et al., 1999). Antagonistic relationships were also noted between metabolic disorders (DA, KET) and conformation traits, such as frame and rear udder height. A similar, negative relationship between metabolic disease and body size was reported in the Minnesota body size selection project (Jones et al., 1994; Hansen et al., 1999).
Sire PTA for clinical MAST were positively correlated with PTA for all udder traits, most notably udder depth (0.20), indicating that selection for desirable udder conformation is likely to reduce mastitis incidence. This result was previously reported by Rogers et al. (1991, 1999), and it most likely occurs because cows with correct udder conformation stay cleaner, avoid injury, and milk out more completely.
The availability of incidence data for common dairy disorders necessitates the development of a coherent, user-friendly approach for reporting sire evaluations and incorporating these into genetic selection programs. Given a multiple-trait genetic evaluation model, such as the model presented herein, one can compute the individual probability of each disease among progeny of a particular sire or the joint probability of several diseases among progeny of this sire.
In the present study, probabilities of disease were expressed in 6 different ways: 1) probability of a metabolic disorder (DA or KET); 2) probability of an early lactation disorder (DA, KET, or MET); 3) probability of a reproductive disorder (CYST or MET); 4) probability of any disorder except mastitis (DA, KET, LAME, CYST, or MET); 5) probability of any disorder (DA, KET, MAST, LAME, CYST, or MET), and 6) expected disease cost in first lactation. The latter measure was calculated in the following manner. Guard (1998) estimated the financial loss associated with an episode of DA, KET, LAME, or MET, including labor, veterinary treatment, discarded milk, reduced milk production, and increased risk of culling, as $340, $145, $285, or $300, respectively. In a similar manner, Jasper et al. (1982) estimated the financial loss associated with a case of clinical MAST to be $175. Lastly, Bartlett et al. (1986) estimated the financial loss associated with a case of CYST to be $170. One might argue that the cost of CYST has decreased over time because of the availability of ultrasound technology and inexpensive hormonal synchronization programs. Furthermore, cystic ovaries may not necessarily be a good indicator of a cows ovulatory status (anovular vs. ovular), and direct genetic evaluation of ovulatory status may be preferred, if possible. Lastly, it is important to note that reduced milk production because of disease is already reflected in the PTA milk of each sire, and use of the aforementioned economic values may lead to overestimation of the total financial impact of these diseases if PTA milk is also included in the merit index. Therefore, these calculations should be viewed as an illustration of a potential method to present sire PTA for disease traits, rather than concise estimates of the economic impact of animal disease.
In the present study, the probability of disease among daughters of each sire was multiplied by the corresponding cost of a clinical episode, and these were summed across disorders for a given sire. In this manner, the expected cost of disease in first lactation was computed. For example, for a typical sire with disease probabilities of 0.033 for DA, 0.100 for KET, 0.186 for MAST, 0.196 for LAME, 0.065 for CYST, and 0.096 for MET, the expected cost of disease would be calculated as:
![]() |
Following this approach, all sires would receive an "expected cost of daughter disease in first parity" which would deviate from an average of $153.80, and sires with lower than expected disease costs would be preferred. In practice, it may be more desirable to use deviations from breed average, rather than actual probabilities of disease, so that diseases with higher lactation incidence rates (LIR) are not weighted more heavily. A strategy of this type could be used to incorporate clinical disease traits into the USDA Animal Improvement Programs Lifetime Net Merit index (www.aipl.arsusda.gov). Obviously, the costs of these health disorders vary between farms and between research studies, and accurate and robust estimation of such costs is critical.
Frequency distributions of sire PTA for each of the 6 disease composites are shown in Figures 1
through 6
. Each reflects the probability of disease or expected cost of disease among first-lactation daughters. As shown in Figure 1
, range in sire PTA for "probability of no metabolic disorder" in first-lactation daughters ranged from 0.82 to 0.91. Likewise, as shown in Figure 2
, the "probability of no early lactation disorder" in first parity ranged from 0.62 to 0.76. The "probability of no reproductive disorder" in first parity ranged from 0.64 to 0.81, as shown in Figure 3
, and the "probability of no disease other than mastitis" ranged from 0.52 to 0.67, as shown in Figure 4
. Lastly, the "probability of no disease" in first lactation, ranged from 0.34 to 0.53, as shown in Figure 5
, and the "expected cost of disease" in first lactation ranged from $128 to $169 (Figure 6
).
|
|
|
|
|
|
|
| CONCLUSIONS |
|---|
|
|
|---|
Genetic correlations between individual disease incidences and disease composites with PL and DPR were generally favorable, indicating that PL and DPR improved as disease incidence decreased. However, corresponding relationships with body size and dairy form tended to be antagonistic, indicating that selection for body size and angularity may impair disease resistance. Favorable associations were also found between MAST and both SCS and udder conformation, indicating that selection for improved udders and lower SCS will tend to improve MAST resistance.
Genetic selection based on farmer-recorded disease traits could proceed in various ways. First, individual disease traits could be evaluated, published, and incorporated into an economic index. Although this approach is theoretically preferable, low incidence rates for certain diseases may lead to extreme category problems, and farmers may be faced with sire PTA for an overwhelming number of traits. Second, a multiple-trait model could be used to compute the probability of resistance to all diseases collectively, or the probability of resistance to certain groups of diseases, such as metabolic disorders or reproductive disorders. Such an approach may be appealing to end-users, and it may be more robust to variation in economic values of certain diseases on different farms.
Overall, many challenges exist with respect to data collection, data validation, statistical analysis, determination of economic values, and publication of results. However, trends toward rapid expansion of commercial dairies, greater reliance on herd management software programs, increased interest in health and fertility traits, and larger progeny group size among AI sires bode well for efforts toward development of genetic improvement programs for resistance to common health disorders in US dairy cattle.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
Received for publication July 13, 2004. Accepted for publication September 10, 2004.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. D. R. N. Appuhamy, B. G. Cassell, and J. B. Cole Phenotypic and genetic relationships of common health disorders with milk and fat yield persistencies from producer-recorded health data and test-day yields J Dairy Sci, April 1, 2009; 92(4): 1785 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Heringstad, Y. M. Chang, I. M. Andersen-Ranberg, and D. Gianola Genetic analysis of number of mastitis cases and number of services to conception using a censored threshold model. J Dairy Sci, October 1, 2006; 89(10): 4042 - 4048. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Harder, J. Bennewitz, D. Hinrichs, and E. Kalm Genetic parameters for health traits and their relationship to different persistency traits in German Holstein dairy cattle. J Dairy Sci, August 1, 2006; 89(8): 3202 - 3212. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Snowder, L. D. Van Vleck, L. V. Cundiff, and G. L. Bennett Bovine respiratory disease in feedlot cattle: Environmental, genetic, and economic factors J Anim Sci, August 1, 2006; 84(8): 1999 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Gonda, Y. M. Chang, G. E. Shook, M. T. Collins, and B. W. Kirkpatrick Genetic Variation of Mycobacterium avium ssp. paratuberculosis Infection in US Holsteins J Dairy Sci, May 1, 2006; 89(5): 1804 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Heringstad, Y. M. Chang, D. Gianola, and G. Klemetsdal Genetic Analysis of Clinical Mastitis, Milk Fever, Ketosis, and Retained Placenta in Three Lactations of Norwegian Red Cows J Dairy Sci, September 1, 2005; 88(9): 3273 - 3281. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |